Reports for APO-DEFERASIROX
Brand name
APO-DEFERASIROX
Company Name
APOTEX INC
|
Drug Identification Number
02461552 |
Ingredients
DEFERASIROX |
Ingredient Strength
250 MG |
ATC Code
V03AC |
ATC Descriptor
ALL OTHER THERAPEUTIC PRODUCTS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| APO-DEFERASIROX | 30 BLS | Resolved | 2018-03-13 | 2018-07-03 | 42717 |
| APO-DEFERASIROX | 30 BLS | Resolved | 2020-04-13 | 2020-05-22 | 111901 |
| APO-DEFERASIROX | 30 BLS | Resolved | 2020-08-06 | 2020-11-28 | 121891 |
| APO-DEFERASIROX | 30 BLS | Resolved | 2023-09-07 | 2023-09-15 | 203819 |
| APO-DEFERASIROX | 30 BLS | Actual shortage | 2024-09-27 | 2024-11-29 | 238844 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0